Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Gene Expression-Microarrays Laboratory, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy.
J Virol. 2014 Oct;88(19):11045-55. doi: 10.1128/JVI.00307-14. Epub 2014 Jul 9.
Dendritic cells (DCs) are fundamental for the initiation of immune responses and are important players in AIDS immunopathogenesis. The modulation of DC functional activities represents a strategic mechanism for HIV-1 to evade immune surveillance. Impairment of DC function may result from bystander effects of HIV-1 envelope proteins independently of direct HIV-1 infection. In this study, we report that exposure of immature monocyte-derived DCs (MDDCs) to HIV-1 R5 gp120 resulted in the CCR5-dependent production of interleukin-6 (IL-6) via mitogen-activated protein kinase (MAPK)/NF-κB pathways. IL-6 in turn activated STAT3 by an autocrine loop. Concomitantly, gp120 promoted an early activation of STAT3 that further contributed to IL-6 induction. This activation paralleled a concomitant upregulation of the STAT3 inhibitor PIAS3. Notably, STAT3/IL-6 pathway activation was not affected by the CCR5-specific ligand CCL4. These results identify STAT3 as a key signaling intermediate activated by gp120 in MDDCs and highlight the existence of a virus-induced dysregulation of the IL-6/STAT3 axis. HIV-1 gp120 signaling through STAT3 may provide an explanation for the impairment of DC function observed upon HIV exposure.
This study provides new evidence for the molecular mechanisms and signaling pathways triggered by HIV-1 gp120 in human DCs in the absence of productive infection, emphasizing a role of aberrant signaling in early virus-host interaction, contributing to viral pathogenesis. We identified STAT3 as a key component in the gp120-mediated signaling cascade involving MAPK and NF-κB components and ultimately leading to IL-6 secretion. STAT3 now is recognized as a key regulator of DC functions. Thus, the identification of this transcription factor as a signaling molecule mediating some of gp120's biological effects unveils a new mechanism by which HIV-1 may deregulate DC functions and contribute to AIDS pathogenesis.
树突状细胞(DC)是启动免疫反应的基础,也是艾滋病发病机制中的重要参与者。调节 DC 功能活动是 HIV-1 逃避免疫监测的一种策略机制。DC 功能的损害可能是由 HIV-1 包膜蛋白的旁观者效应引起的,而与 HIV-1 的直接感染无关。在这项研究中,我们报告说,暴露于 HIV-1 R5 gp120 的不成熟单核细胞衍生的树突状细胞(MDDC)会通过有丝分裂原激活的蛋白激酶(MAPK)/NF-κB 途径导致 CCR5 依赖性白细胞介素-6(IL-6)的产生。IL-6 反过来通过自分泌环激活 STAT3。同时,gp120 促进 STAT3 的早期激活,进一步促进 IL-6 的诱导。这种激活与 STAT3 抑制剂 PIAS3 的伴随上调平行。值得注意的是,STAT3/IL-6 途径的激活不受 CCR5 特异性配体 CCL4 的影响。这些结果表明 STAT3 是 gp120 在 MDDC 中激活的关键信号中间物,并强调了存在病毒诱导的 IL-6/STAT3 轴失调。通过 STAT3 的 HIV-1 gp120 信号可能为 HIV 暴露时观察到的 DC 功能受损提供解释。
本研究为 HIV-1 gp120 在不存在有性感染的情况下在人 DC 中触发的分子机制和信号通路提供了新的证据,强调了异常信号在早期病毒-宿主相互作用中的作用,有助于病毒发病机制。我们确定 STAT3 是 gp120 介导的信号级联反应中的关键组成部分,该信号级联反应涉及 MAPK 和 NF-κB 成分,最终导致 IL-6 的分泌。STAT3 现在被认为是 DC 功能的关键调节因子。因此,将这种转录因子鉴定为介导 gp120 部分生物学效应的信号分子揭示了 HIV-1 可能使 DC 功能失调并有助于艾滋病发病机制的新机制。